Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study
Authors
Keywords
Epirubicin, Advanced breast cancer, Precision medicine, Predictive biomarker
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-11
DOI
10.1007/s10549-018-4918-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic and predictive biomarkers in breast cancer: Past, present and future
- (2017) Andrea Nicolini et al. SEMINARS IN CANCER BIOLOGY
- Abstract CT154: Phase I dose-escalating PoC study to evaluate the safety and tolerability of LiPlaCis (liposomal cisplatin formulation) in patients with advanced or refractory tumors
- (2016) Ulrik Lassen et al. CANCER RESEARCH
- Cell Line Derived 5-FU and Irinotecan Drug-Sensitivity Profiles Evaluated in Adjuvant Colon Cancer Trial Data
- (2016) Ida Kappel Buhl et al. PLoS One
- Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) E. Senkus et al. ANNALS OF ONCOLOGY
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Predicting Anthracycline Benefit:TOP2Aand CEP17—Not Only but Also
- (2015) John M.S. Bartlett et al. JOURNAL OF CLINICAL ONCOLOGY
- Development and Blind Clinical Validation of a MicroRNA Based Predictor of Response to Treatment with R-CHO(E)P in DLBCL
- (2015) Steen Knudsen et al. PLoS One
- Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells
- (2014) Harris Wang et al. BMC CANCER
- Personalized medicine: Present and future of breast cancer management
- (2014) Renaud Sabatier et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Development and Validation of a Gene Expression Score That Predicts Response to Fulvestrant in Breast Cancer Patients
- (2014) Steen Knudsen et al. PLoS One
- Quantification of residual risk of relapse in breast cancer patients optimally treated
- (2013) Maria Vittoria Dieci et al. BREAST
- Independent Validation of a Model Using Cell Line Chemosensitivity to Predict Response to Therapy
- (2013) Wenting Wang et al. JNCI-Journal of the National Cancer Institute
- Which patients with metastatic breast cancer benefit from subsequent lines of treatment? An update for clinicians
- (2013) Raffaella Palumbo et al. Therapeutic Advances in Medical Oncology
- Epirubicin: Is it like doxorubicin in breast cancer? A clinical review
- (2012) Mustafa Khasraw et al. BREAST
- Gene expression alterations in doxorubicin resistant MCF7 breast cancer cell line
- (2012) Shatha AbuHammad et al. GENOMICS
- A 71-Gene Signature of TRAIL Sensitivity in Cancer Cells
- (2011) J.-J. Chen et al. MOLECULAR CANCER THERAPEUTICS
- Treatment of metastatic breast cancer: second line and beyond
- (2010) H. Roche et al. ANNALS OF ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now